Clarify benefits of transgenic mice in biomedical research

Those promoting misinformation regarding federal funding for transgenic mouse research should be corrected. Transgenic mice are genetically engineered animals created by introducing foreign DNA into their genome, not "transgender mice" as stated. These model organisms are crucial for studying human diseases and developing treatments, adhering to strict ethical oversight. Mario R. Capecchi, Ph.D., of the University of Utah, won the 2007 Nobel Prize in Physiology or Medicine for pioneering work on "knockout mouse" technology, a gene-targeting technique that has revolutionized genetic and biomedical research, allowing scientists to create animal models for hundreds of human diseases. Spreading inaccurate claims about this important biomedical research undermines scientific progress and public trust. We must ensure elected officials have a proper understanding of transgenic technology and its benefits before criticizing related expenditures. Providing accurate information on the significance of this work in advancing therapies for cancer, Alzheimer's, and other conditions is vital for informed policymaking decisions.